Background: Epigenetic gene regulation is important in human cancer.
Introduction
HEPATOCELLULAR Carcinoma (HCC) is the fifth most prevalent cancer disease worldwide [1] .
Correspondence to: Dr. Abd El-Hady A. Abd El-Wahab, E-Mail: abdelhady.abdelwahab@nci.cu.edu.eg Chronic liver injury, that results in inflammation, hepatocyte regeneration, liver matrix transforming, fibrosis, and, finally, cirrhosis can cause HCC development [2] . In addition to numerous genetic causes, the development and progression of HCC is strongly correlated with epigenetic pattern of DNA and histone modifications. In the last decade, Histone Acetylases (HATs) and Histone Deacetylases (HDACs) have shown important roles in the regulation of transcription [3] . Histone Deacetylase Inhibitors (HDACi) can affect angiogenesis, cell differentiation and apoptosis [4] . Sodium Butyrate (SB) is one of the short chain fatty acids naturally formed in gastrointestinal tracts. SB can cause cell cycle arrest, apoptosis and stimulate cell differentiation in multi type of cancer cells lines notably the colon [5] breast [6] , liver [7] . SB, a histone deacetylases inhibitor, can induce broad alteration in chromatin structure and expression of genes [1] . SB has been shown to inhibit proliferation in different cancer cell lines high efficiency and very low general toxicity [8] [9] [10] [11] .
It has been shown that histone deacetylation plays a vital role as a regulator for microRNAs (miRNAs) expression [12] . MiRNAs are a small non-coding RNAs of ~22 nucleotides that regulate gene expression machinery. There is rising attention in recognizing the harmony between miRNA expression in cancer disease, chemo-and radiosensitivity to enhance the performance of the treatment manner through prediction or modulation of sensitivity or response [13] .
The goal of the present study is to investigate the effects of acetylation level alterations by SBon HCC cell lines survival and incontrolling the expression of five miRNAs, known to be involved 271 272 Alterations of Some MicroRNAs Expression in HCC Lines by Sodium Butyrate incell proliferation, apoptosis, angiogenesis and metastasis.
Material and Methods

Cell lines:
The human HCC cell lines, HepG2 and Huh7 used in the current study, wereobtainedfrom VAC-SERA (the Egyptian Company for Production of Vaccines, Sera and Drugs). The cell lines were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (Gibco,USA), 100U/ml penicillin and 100µ g/ml streptomycin at 37ºC in a humidified 5% CO2 incubator (Thermo Scientific, City, USA). SB was obtained from Sigma-Alderish (Merck KGaA, Germany). SB stock solution was prepared at a concentration of 250mM in distilled water and stored at -20ºC.
This study was conducted at National Cancer Institute, Cairo University (NCICU) from August 2015 -December 2017.
Cell viability assay:
The cytotoxic effect of SB was determined using SulphoRhodamine-B assay (SRB) as described previously [14] . Cells were seeded onto 96well plates (5 X 10 3 /well) corresponding to 75% confluence, for 24h. The cells were treated with 7 different concentrations of SB (0.25, 0.5, 2, 5, 6, 8 and 12mM) and incubated at 37ºC in a humidified 5% CO2 incubatorfor another 48h. Untreated cells (control cells) seeded in parallel in serum free media. After incubation, cell fixation was done by treatmentwith TCA to a final concentration 10% for 30min. SRB (0.4%) was added for 30min, then cells were washed with 1% Acetic acid. 10mM Tris base were added and the absorbance was recorded on a microplate reader (Tecan Sunrise, Austria) at a wavelength of 570nm. Each treatment wasdone in triplicates. The sub-lethal inhibitory concentrations of SB (IC20, IC35 and IC50) were calculated and selected for use in the following experiments as shown in (Table 1) and Fig. (1) .
MiRNAsextractionand quantitative real-time PCR analysis:
Total RNA (including miRNAs) from HepG2 and Huh7 cell lines, before and after treatment with SB, was extracted using miRNeasy kit as described in the manufacturer's instructions (Qiagen, Germany). RNA was purified using miRNeasy MinElute spin columns (Qiagen, City, Country) then eluted in 35 µ l RNase-free water. RNA concentrations were quantified using NanoDrop-Onespectrophotometer (Thermo Scientific, City, USA). Total RNA (250ng/sample) was reversetranscribed using miScript RT kit (Qiagen). Reactions were incubated at 37ºC for 1h followed by inactivation of the reaction by incubation at 95ºC for 5min.
The expression levels of miR-133b, miR-26a-5p, miR-122-5p, miR-518f-3p and miR-539-5p were measured using miScript SYBER Green reagent kit (Qiagen) according to the manufacturer's protocol. About 5ng of cDNA was used as template in a 10µ l PCR reaction containing 1X SYBR Green master mix, 1XmiRNA specific forward primer, and 1X universal primer. The conditions for qRT-PCR were as follows: 95ºC for 10min, followed by 40 cycles of 95ºC for 15s and 55ºC for 1min. All the RT-qPCR reactions were performed on ViiA7 real-time PCR system (Applied Biosystems, USA). All samples were performed in duplicate. U6 snRNA was used as an endogenous control for normalization. The relative expression analysis of miRNAs studied was performed using comparative Ct method [15] .
Data analysis:
The obtained real time data was analysed using ∆∆ Ct comparative method. U6 was used as an endogenous control and its Ct values were subtracted from the examined miRNA Ct values to obtain ∆Ct. The fold of change was calculated from the following formula: Fold of change = 2 -∆∆Ct .
Statistical analysis:
The significant difference in cytotoxicity assay values was evaluated using one-way ANOVA, followed by the Dunnett's multiple comparison test. Data are presented as means ± SD. Statistical analyses were performed using GraphPad Prism Version 5 for windows (GraphPad Software Inc., city, USA). p-value <0.05 wasconsidered significant.
Bioinformatics analysis:
MiRTarBasedatabase (http://mirtarbase. mbc. nctu.edu.tw/php/index.php) (January 2018) and MirOBdatabase (http://mirob.interactome.ru/) (January 2018) were used to identify the experimentallyvalidated targetsand the related pathwaysof theexamined miRNAsinthis study. GeneCardsdatabase (http://www.genecards.org/) has been adoptedto identify possible functionsof the validated targets.
Results
In this study we investigated the cellular effects ofthree sub-lethaldoses of SB treatment on liver Reham Srour, et al. 273 cancer cell lines (HepG2 and Huh7) survival andon the expression level of 5-selected miRNAs.
Cytotoxicity of SB on liver cancer cell lines (HepG2 and Huh7):
To determine theeffect of SB onHepG2 and Huh7, cells were exposed to 7 concentrations of SB ranging from (0.25, 0.5, 2, 5, 6, 8, and 12mM) for 48h, and then cell viability were measured using SRB assay. Our data revealed a concentrationdependent decrease in the survival rate with SB treatment Fig. (1) in both cell lines examined. Notably, HepG2 cells exhibited a higher sensitivity to SB treatment compared to Huh7. Detected IC20, IC35, and IC50 concentrations were used for further analyses Fig. (1) and (Table 1) .
Quantitative RT-PCR assay:
The effect of three different concentrations of SB (IC20, IC35, and IC50) on the expression level of selected miRNAs was examined. The examined miRNAs revealed different expression level between the two cell lines ( Table 2) .
Pathway predication:
miRTarBase, MirOB and Gene Cards have (Janaury 2018) been searched to identify experi-mentally validated targets of selected miRNAs andtheirsuggested functions and related pathways. Interestingly, the revealedtarget genes signaling areinvolved, to some extent, incell death, proliferation and survival. • Acts as anti-apoptotic.
[16] IGF1R
• Acts as anti-apoptotic.
[18] FAIM
• Involved in extrinsic anti-apoptotic pathway.
[19] FSCN1
• Involved in metastasis.
[20] EGFR
• Induces proliferation.
[21] FGFR1
• Involved in migration and angiogenesis.
[22] MET • Acts as oncogenic and involved in resistance to drug.
[23] GLI1
• Induces migration.
[24] Hsa-miR-26a-5p HMGA 1 • Involved in metastasis.
[25] MTDH
• Involved in tumor cell expansion and metastasis.
[26] FGF9
• Induces cell survival, tumor growth and invasion.
[27] HGF
• Involved in angiogenesis, tumorigenesis and tumor regeneration.
[28] PIK3C2A
• Induces proliferation and cell survival. [30]
MAPK11
• Involved in cellular proliferation.
[31] AKT3
• Regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis.
[32]
BCL2L2
• Involved in intrinsic anti-apoptotic pathway.
[33] Hsa-miR-539-5p TWIST1
• Promotes tumor cell invasion and metastasis.
[34] ZEB1
• Induces an Epithelial-Mesenchymal Transition (EMT) and promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
[35]
Hsa-miR-518f-3p RBM8A • Inhibits formation of proapoptotic isoforms such as Bcl-X.
[36] STK4
• Act as pro-apoptotic kinase.
[36] TYRO3
• Has role in controlling cell survival and proliferation, spermatogenesis, immunoregulation and phagocytosis.
[36]
RPS6KA3 • Regulates diverse cellular processes such as cellular growth, motility, survival and proliferation. 
Discussion
The histone deacetylase inhibitor (HDACi), Sodium Butyrate, is a component of short-chain fatty acids produced by anaerobic fermentation of dietary fibers in the gastrointestinal tract of mammalian species [37] . SB can inhibit cell proliferation and potentiate cancer therapy and prevention via inhibition of HDACs, that makes it a good candidate for cancer management. It has been shown that HDACi play a vital role as regulators for many miRNAs [38] . Thus, understanding their specific role could changes the therapeutic strategies for cancer.
The present data displayed decreasein cell growth of HepG2 and Huh7 liver cell lines when treated with SB in a dose-dependent manner, which is consistence with previous studies [9] . Further-more, HepG2 cells revealed higher sensitivity upon treatment with SB than Huh7 cells, their IC50 values were 6.7mM and 9.2mM, respectively. Previous studies have reported that cytotoxicity of SB was in the range of 1.47mM to 5mM for HepG2 [11, 39] and 2mM in Huh7 [40] which are different from our detected IC50 values. This might be due to the difference in the number of passages of each cell line. Meanwhile, the variation between the two cell linesmight be attributed to the variation in their biological and geneticcharacteristics such as difference in p53expression as well as expression of certain proteins such as α -feto protein, and others in HepG2 cells [41] .
It has been shown that SB might induce profound changes in miRNA expression of HCC cells [42] . MiRNA scan have extensive effects through regulation of a variety of genes that are involved in the most vital cellular processes including, differentiation and cell cycle regulation [43, 44] .
The present data shows an up-regulation of miR-133b expression level in HepG2 cells, treated with SB, in a dose-dependent manner whereas, it is down-regulated in Huh7 with low dose treatment. Previous studies haveshown that treatment of gastric cancer cell lines with SAHA (HDAC inhibitor) increases the expression level of miR-133b/a-3p and decreases acetylation which refers to the role of histone acetylation in regulation of miR-133b expression [21] . Our gene target analysis by Gene-Cards database suggests that miR-133b might have a pro-apoptotic function as it seems to target a number of anti-apoptotic genes ( Table 3 ). This is consistent with several studies that have shown down regulation of miR-133b level in different types of cancer [45, 46] and this change was significantly associated with poor survival and distant metastasis in colorectal carcinoma [47] . Overexpression of miR-133b can boost apoptosis through TRAIL pathway as detected in HeLa cells [19] . Apoptosis can be also induced via controlling the expression of Bcl2 family as shown in lung cancer and bladder cancer by mir-133b [48] . MiR-133b can affect cell proliferation and apoptosis through suppressing c-Met signaling pathways in colorectal carcinoma [49] . Previous study showed that miR-133b can inhibit target gene silent information regulator 1 (Sirt1) that lead to suppression of cell proliferation and invasion in hepatocellular carcinoma [50] . Down-regulation of miR-133b was significantly correlated with primary resistance ovarian carcinomas [51] which refers to its crucial role in chemotherapeutic efficacy of cancer. On the other hand, a recent study showed that miR-133b can reduce the phosphorylation of Erk1/2 and Akt by targeting EGFR in ovarian cancer [21] .
The role of miR-26a-5p in carcinogenesis appears to be morecomplicated as it has both oncogenic and tumor suppressive effect in cancers including hepatocellular carcinoma cells [39] . Using HDAC inhibitor, up-regulation of miR-26a was recorded in human umbilical cord-blood multipotent stem cells (hUCB-MSCs) that plays important roles in cellular senescence via targeting highmobility group A2 protein (HMGA2) [52] . It was shown that miR-26a acts as tumor suppressor in a variety of cancers [53, 54] . MiR-26a-5p is often downregulated in several tumor tissues and tumor cell lines [54] . MiR-26a was able to suppress the proliferation, migration, and invasion of cells via negative regulation of MTDH, which supported the role of miR-26a as tumor suppressor in HCC cells [55] . In addition, it was found that miR-26a has the potency to suppress tumor growth and metastasis by regulating FGF9 [56] . On the other hand, miR-26a was found to enhance metastasis of lung cancer by directly targetingthe tumor suppressor PTEN and thusactivating AKT signaling pathway [26] .
Our results showed a down regulation of miR-26a at low doses treatment (IC20 and IC35) whereas it was up regulated at high doses (IC50) in hepatocellular cells which is correlated with inhibition of cell proliferation. This might be due to thedual effect of SB, which means low concentrations of SB can produce a significant increase in cell growth in cell line, while unlikeness high concentrations of it can inhibit cell growth in the same cell line [57] .
MiR-122-5p has been found to be closely associated with HCC [58] . In this study, we found that miR-122-5p was significantly down regulated in HepG2 and Huh7 cells treated with different concentrations of SB compared to control cells. Down expression of miR-122-5p was reported to cause inhibition of HCC cell proliferation, migration, and invasion by the targeting of IGF1R, MAPK11 and BCL2L2. BCL2L2 is one of the main inhibitors to intrinsic apoptotic pathway by reducing the activation of some essential pathways, such as c-Myc, IGF, and Wnt/(3 -catenin [59] . MiR-122-5p inhibits Akt3, which regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis [60] . The metastatic and invasive property of HCC cells was also demonstrated to be suppressed by miR-122 in an ADAM17-dependent mechanism [31] . In addition, other studies revealed that miR-122 can induce apoptosis by inhibiting Bcl-w transcription [61] .
Although miR-539-5p has been shown to be involved in other types of cancers, our study showed significant downregulation in both cells treated with different concentrations of SB compared with untreated cells. Other studies reported that miR-539-5p was downregulated inosteosarcoma and suppresses tumor metastasis by targeting MMP8 and acts as an oncogene or tumor suppressor in different types of cancer [62] .
MiR-518f-3p was significantly up regulated in HepG2 and Huh7 cells treated with different concentrations of SB compared with untreated cells, which is in agreement withone studythat showed a significant up-regulationof miR-5 1 8f-3p in HCC [63] . According tomiRTarebaseand Gene Cards database miT-518f-3p inhibited TYRO3 and RPS6KA3. Other studies showed that TYRO3 iscontrolling cell survival and proliferation in breast cancer [64] . Further studies are required to understand the possible role of miR-518f-3p in HCC.
Taken together, our results suggested that the biological effects at different concentrations of SBmight have different mechanisms at the cellular machinery level. Further studies are neededto elucidate this observationand its potent therapeutic effectsfor HCC. 
